WeLeader Biomedical Co (7713.TWO) Stock Price
WeLeader Biomedical Co Price
Over the last 5 years WeLeader Biomedical Co grew revenue by 10.5% annually, reaching 1.11 B TWD. Earnings per share have grown at 31.2% per year over the last 5 years. For WeLeader Biomedical Co, the net margin of 18.8% is up versus 12.6% a few years ago. At today's price the dividend yield works out to roughly 4.58%. The payout ratio is around 73% of earnings.
WeLeader Biomedical Co stock price
WeLeader Biomedical Co business model & stock analysis
Frequently asked questions about WeLeader Biomedical Co
Converted at the current exchange rate, the WeLeader Biomedical Co share trades at 2.05 EUR (73.50 TWD).
The expected revenue of WeLeader Biomedical Co is 1.15 B TWD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of WeLeader Biomedical Co is 217.39 M TWD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of WeLeader Biomedical Co is currently 15.38. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the WeLeader Biomedical Co stock.
The price-to-sales ratio (P/S) of WeLeader Biomedical Co is currently 2.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the WeLeader Biomedical Co stock.
The Eulerpool Quality Score for WeLeader Biomedical Co is 3/10.
The ISIN of WeLeader Biomedical Co is TW0007713000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of WeLeader Biomedical Co is 7713.TWO. The ticker symbol is used to trade WeLeader Biomedical Co shares on the stock exchange.
WeLeader Biomedical Co stock
WeLeader Biomedical Co Peer Group
All fundamentals and in-depth analysis of WeLeader Biomedical Co
Our stock analysis for WeLeader Biomedical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WeLeader Biomedical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.